Basic Information
| LncRNA/CircRNA Name | circ_0000594 |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | Hepatoblastoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR, CCK-8 and colony formation, transwell, and flow cytometry assays |
| Sample | Hepatoblastoma tissues |
| Expression Pattern | up-regulated |
| Function Description | Expression levels of hsa_circ_0000594 were significantly upregulated in HB tissues compared with those in paired normal liver tissues and showed a clear association with the subtype of HB. |
| Pubmed ID | 31646606 |
| Year | 2019 |
| Title | Characterization of hsa_circ_0000594 as a New Biomarker and Therapeutic Target for Hepatoblastoma |
External Links
| Links for circ_0000594 | GenBank HGNC NONCODE |
| Links for Hepatoblastoma | OMIM COSMIC |